drug systems affecting availability and reliability of response

Brodie, 1957, J. Pharmacol London, 9, 345, 10.1111/j.2042-7158.1957.tb12289.x Schanker, 1957, J. Pharmacol, 120, 528 Hogben, 1957, J. Pharmacol, 120, 540 Shore, 1957, J. Pharmacol, 119, 361 Schanker, 1958, J. Pharmaco, 81, 123 Hogben, 1959, J. Pharmacol, 125, 275 Schanker, 1959, J. Pharmacol, 126, 283 Schanker, 1960, J. Med. Pharm. Chem., 2, 343, 10.1021/jm50011a001 Schanker, 1961, Ann. Rev. Pharmacol, 1, 29, 10.1146/annurev.pa.01.040161.000333 Schanker, 1962, Pharmacol. Rev., 14, 501 Brodie, B. B. in Absorption and Distribution of Drugs, T. B. Binnis, ed., E. and S. Livingston, Ltd., London (1964). Garrett, 1962, J. Pharm. Sci, 51, 387, 10.1002/jps.2600510422 Garrett, 1962, J. Pharm. Sci., 51, 410, 10.1002/jps.2600510503 Garrett, 1960, JAPhA, Sci, Ed., 49, 767 Garrett, 1965, J. Pharm. Sci., 54, 119, 10.1002/jps.2600540127 Noyes, 1897, J. Am. Chem. Soc, 19, 930, 10.1021/ja02086a003 Hixson, 1931, Ind. Eng. Chem., 23, 923, 10.1021/ie50260a018 Parrott, 1955, JAPhA, Sci, Ed., 44, 269 Wurster, 1960, JAPhA, Sci, Ed., 49, 335 Wurster, 1965, J. Pharm. Sci., 54, 169, 10.1002/jps.2600540202 Higuchi, 1963, J.Pharm. Sci, 52, 150, 10.1002/jps.2600520210 Mullins, 1960, JAPhA, Sci, Ed., 49, 245 Higuchi, 1958, JAPhA, Sci, Ed., 47, 657 Higuchi, 1958, JAPhA, Sci, Ed., 47, 376 Wagner, 1961, J. Pharm. Sci., 50, 359, 10.1002/jps.2600500502 Glazko, A. J., Edgerton, W., Dill, W., and Lenz, W., Antibiot. Chemotherapy, 2, 234 (1952); Glazko, A. J., Dill, W. A., Kazen-ko, A., Wolf, L. M., and Carnes, H. E., Antibiot. Chemotherapy, 8, 516 (1958) Nelson, 1961, J. Pharm. Sci., 50, 181, 10.1002/jps.2600500302 Wagner, 1964, Antibiot, Chemotherapy, 12, 53 Morrison, 1965, J. Pharm. Sci., 54, 1, 10.1002/jps.2600540102 Levy, 1967, Congr. of Pharma-ceut. Sci, 58 Levy, G., and Nelson, E., JAMA, 117, 689 (1961); Levy, G., and Nelson, E., N.Y.J. of Med., 61, 4003 (1961). Nelson, 1957, JAPhA, Sci, Ed., 46, 607 Aguiar, 1967, J. Pharm. Sci., 56, 847, 10.1002/jps.2600560712 Brudney, N., Stewart, D. J., and Eustace. B. T., Canad. Med. Ass. J., 90, 980 (1964). Levy, 1964, Canad. Med. Assoc. J., 90, 978 Riegelman, 1962 Morozowich, 1962, J. Pharm. Sci., 51, 993, 10.1002/jps.2600511020 Juncher, 1957, A. M. and C. T., 4, 497 Campagna, 1963, J. Pharm. Sci., 52, 605, 10.1002/jps.2600520626 Levy, 1964, Am. J. Hosp. Pharm., 21, 402 Levy, 1960, J. Pharm. Sci., 50, 388, 10.1002/jps.2600500503 Boyd, 1947, Am. J. Med. Sci., 213, 549, 10.1097/00000441-194705000-00004 Reinhold, 1945, Am. J. Med. Sci, 210, 141, 10.1097/00000441-194508000-00001 Levy, 1962, 723 Lozinski, 1960, Canad. Med. Assoc. J., 83, 177 Singh, 1966, J Pharm. Sci., 55, 63, 10.1002/jps.2600550114 Hurwitz, 1963, J. Pharm. Sci., 52, 893, 10.1002/jps.2600520917 Boger, 1959, New Eng. J. of Med., 261, 827, 10.1056/NEJM195910222611701 Carter, 1963, Canad. Med. Assn. J., 88, 950 Chapman, D. G., Crisafio, R., and Campbell, J. A., JAPhA, Sci. Ed., 43, 297 (1954); Morrison, A. B., Chapman, D. G., andCampbell, J. A., ibid, 48, 634 (1959). Wagner, 1960, JAPhA, Sci, Ed., 49, 133 Clark, R. L., and Lasagna, L., Clin. Pharmacol and Therap., 6, 568 (1965); Corbus H. P., Calif. Med., 100, 364 (1964). Catz, 1962, New Eng. J. of Med., 260, 136, 10.1056/NEJM196201182660308 Luther, 1952, Review of Vit, Research, 23, 3 Castello, 1962, J. Pharm. Sci., 51, 106, 10.1002/jps.2600510204 Ribeiro, 1955, JAPhA, Sci, Ed., 44, 226 Troup, 1964, J. Pharm. Sci., 53, 375, 10.1002/jps.2600530406 Schroeter, 1958, JAPhA, Sci, Ed., 47, 723 Cannell, 1951, J. Pharm. Pharmac, 3, 741, 10.1111/j.2042-7158.1951.tb13118.x Ikeda, K., Pharm. Bull. (Tokyo), 5, 101 (1957). Stephens, 1959, JAPhA, Sci, Ed., 48, 620 Josselyn, 1953, Antibiotics and Chemotherapy, 3, 63 Anderson, 1959, JAPhA, Sci, Ed., 48, 623